Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

GYRE THERAPEUTICS INC COM (GYRE)

41 + Investors. Track Smart Money conviction in GYRE. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -2
Streak
2Q ▼
Buyers last Q
68%

Smart Money Signals — GYRE

Based on 41 hedge funds · latest filing: 2025 Q4 · updated quarterly

📉

Selling streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds reduced or closed their GYRE positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 91% of 3.0Y peak

91% of all-time peak
41 funds currently hold this stock — 91% of the 3.0-year high of 45 funds (reached 2025 Q2). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +17% more funds vs a year ago

fund count last 6Q
+6 new funds entered over the past year (+17% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟢

More buyers than sellers — 68% buying

26 buying12 selling
Last quarter: 26 funds were net buyers (3 opened a brand new position + 23 added to an existing one). Only 12 were sellers (7 trimmed + 5 sold completely). A clear majority buying is a strong confirmation signal.
⚠️

Fewer new buyers each quarter (-6 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 10 → 9 → 9 → 3. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
📌

Mixed — 27% long-term, 27% new

27% conviction (2yr+) 46% medium 27% new
Of the 41 current holders: 11 (27%) held >2 years, 19 held 1–2 years, and 11 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
📊

Peak discovery — momentum slowing

2 → 10 → 9 → 9 → 3 new funds/Q
New funds entering each quarter: 10 → 9 → 9 → 3. GYRE is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
📊

Mixed cohorts — 5% veterans, 24% new entrants

5% veterans 71% 1-2yr 24% new
Of 41 current holders: 2 (5%) held 2+ years, 29 held 1–2 years, 10 (24%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
🏆

Elite ownership — 75% AUM from top-100 funds

75% from top-100 AUM funds
19 of 41 holders are among the 100 largest funds by AUM, controlling 75% of total institutional value in GYRE. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.3
out of 10
Low Exit Risk
Exit risk score 3.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Hedge Fund Ownership: GYRE

How many hedge funds hold GYRE — quarterly history vs. share price
Quarterly hedge fund ownership of GYRE vs. share price

Market Analysis: GYRE

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: GYRE

-- --
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

17 top-rated funds 0 high-conviction
Consensus
5.5
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: GYRE
2026 Q1 Stats Unlock in 21 days 41 + Investors

Track Smart Money conviction in GYRE. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 41 43 -4.65%
13F Shares 3M 3M 9.11%
Total Value $22M $22M 3.27%
New Positions 3 9 -6
Increased Positions 23 14 +9
Closed Positions 5 11 -6
Reduced Positions 7 14 -7
Total Calls 0 0 -
Total Puts 1 0 100%
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: GYRE

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

41 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in GYRE. Verified SEC 13F-HR filings.

Top 9 institutional holders of GYRE — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 SBI Securities Co., Ltd. 0.03% 170,837 $1.2M
2 Activest Wealth Management 0.00% 533 $4K
3 STRS OHIO 0.00% 21,100 $147K
4 State of Alaska, Department of Revenue 0.00% 5,219
5 Police & Firemen's Retirement System of New Jersey 0.00% 2,097 $15K
6 GoalVest Advisory LLC 0.00% 50
7 GAMMA Investing LLC 0.00% 82
8 Sterling Capital Management LLC 0.00% 59
9 MassMutual Private Wealth & Trust, FSB 0.00% 12
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — GYRE THERAPEUTICS INC COM (GYRE)

What does the Smart Money Trend signal show for GYRE?

Selling streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds reduced or closed their GYRE positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for GYRE?

More buyers than sellers — 68% buying: Last quarter: 26 funds were net buyers (3 opened a brand new position + 23 added to an existing one). Only 12 were sellers (7 trimmed + 5 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for GYRE holders?

Elite ownership — 75% AUM from top-100 funds: 19 of 41 holders are among the 100 largest funds by AUM, controlling 75% of total institutional value in GYRE. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held GYRE?

Mixed — 27% long-term, 27% new: Of the 41 current holders: 11 (27%) held >2 years, 19 held 1–2 years, and 11 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.